476 related articles for article (PubMed ID: 27825009)
1. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial.
Brucato A; Imazio M; Gattorno M; Lazaros G; Maestroni S; Carraro M; Finetti M; Cumetti D; Carobbio A; Ruperto N; Marcolongo R; Lorini M; Rimini A; Valenti A; Erre GL; Sormani MP; Belli R; Gaita F; Martini A
JAMA; 2016 Nov; 316(18):1906-1912. PubMed ID: 27825009
[TBL] [Abstract][Full Text] [Related]
2. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
Imazio M; Andreis A; De Ferrari GM; Cremer PC; Mardigyan V; Maestroni S; Luis SA; Lopalco G; Emmi G; Lotan D; Marcolongo R; Lazaros G; De Biasio M; Cantarini L; Dagna L; Cercek AC; Pivetta E; Varma B; Berkson L; Tombetti E; Iannone F; Prisco D; Caforio ALP; Vassilopoulos D; Tousoulis D; De Luca G; Giustetto C; Rinaldi M; Oh JK; Klein AL; Brucato A; Adler Y
Eur J Prev Cardiol; 2020 Jun; 27(9):956-964. PubMed ID: 31610707
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
[TBL] [Abstract][Full Text] [Related]
4. Recurrent pericarditis in children and adolescents: a multicentre cohort study.
Imazio M; Brucato A; Pluymaekers N; Breda L; Calabri G; Cantarini L; Cimaz R; Colimodio F; Corona F; Cumetti D; Cuccio CD; Gattorno M; Insalaco A; Limongelli G; Russo MG; Valenti A; Finkelstein Y; Martini A
J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):707-12. PubMed ID: 27467459
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis.
Collini V; Andreis A; De Biasio M; De Martino M; Isola M; Croatto N; Lepre V; Cantarini L; Merlo M; Sinagra G; Abbate A; Lazaros G; Brucato A; Klein AL; Imazio M
Open Heart; 2024 Mar; 11(1):. PubMed ID: 38490715
[TBL] [Abstract][Full Text] [Related]
6. Colchicine for recurrent pericarditis (CORP): a randomized trial.
Imazio M; Brucato A; Cemin R; Ferrua S; Belli R; Maestroni S; Trinchero R; Spodick DH; Adler Y;
Ann Intern Med; 2011 Oct; 155(7):409-14. PubMed ID: 21873705
[TBL] [Abstract][Full Text] [Related]
7. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial.
Imazio M; Belli R; Brucato A; Cemin R; Ferrua S; Beqaraj F; Demarie D; Ferro S; Forno D; Maestroni S; Cumetti D; Varbella F; Trinchero R; Spodick DH; Adler Y
Lancet; 2014 Jun; 383(9936):2232-7. PubMed ID: 24694983
[TBL] [Abstract][Full Text] [Related]
9. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
Ben-Zvi I; Kukuy O; Giat E; Pras E; Feld O; Kivity S; Perski O; Bornstein G; Grossman C; Harari G; Lidar M; Livneh A
Arthritis Rheumatol; 2017 Apr; 69(4):854-862. PubMed ID: 27860460
[TBL] [Abstract][Full Text] [Related]
10. Goflikicept and Related IL-1 Inhibitors in the Treatment of Recurrent Pericarditis.
Feldman JM; Frishman WH; Aronow WS
Cardiol Rev; 2024 May; ():. PubMed ID: 38709249
[TBL] [Abstract][Full Text] [Related]
11. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial.
Imazio M; Brucato A; Ferrazzi P; Pullara A; Adler Y; Barosi A; Caforio AL; Cemin R; Chirillo F; Comoglio C; Cugola D; Cumetti D; Dyrda O; Ferrua S; Finkelstein Y; Flocco R; Gandino A; Hoit B; Innocente F; Maestroni S; Musumeci F; Oh J; Pergolini A; Polizzi V; Ristic A; Simon C; Spodick DH; Tarzia V; Trimboli S; Valenti A; Belli R; Gaita F;
JAMA; 2014 Sep; 312(10):1016-23. PubMed ID: 25172965
[TBL] [Abstract][Full Text] [Related]
12. Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis.
Andreis A; Imazio M; Giustetto C; Brucato A; Adler Y; De Ferrari GM
Heart; 2020 Oct; 106(20):1561-1565. PubMed ID: 32868281
[TBL] [Abstract][Full Text] [Related]
13. Anakinra effectiveness in refractory polyserositis: An Italian multicenter study.
Lopalco G; Venerito V; Brucato A; Emmi G; Giacomelli R; Cauli A; Piga M; Parronchi P; Nivuori M; Malandrino D; Ruscitti P; Vitiello G; Fabiani C; Cantarini L; Iannone F
Joint Bone Spine; 2022 Mar; 89(2):105299. PubMed ID: 34656754
[TBL] [Abstract][Full Text] [Related]
14. CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials--two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale.
Imazio M; Cecchi E; Ierna S; Trinchero R;
J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):830-4. PubMed ID: 17885522
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
[TBL] [Abstract][Full Text] [Related]
16. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
Klein AL; Imazio M; Cremer P; Brucato A; Abbate A; Fang F; Insalaco A; LeWinter M; Lewis BS; Lin D; Luis SA; Nicholls SJ; Pano A; Wheeler A; Paolini JF;
N Engl J Med; 2021 Jan; 384(1):31-41. PubMed ID: 33200890
[TBL] [Abstract][Full Text] [Related]
17. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial.
Imazio M; Bobbio M; Cecchi E; Demarie D; Pomari F; Moratti M; Ghisio A; Belli R; Trinchero R
Arch Intern Med; 2005 Sep; 165(17):1987-91. PubMed ID: 16186468
[TBL] [Abstract][Full Text] [Related]
18. [Anti-interleukin-1 agents: a new class of drugs for recurrent pericarditis. A practical guide for cardiologists].
Imazio M; Lazaros G; Gattorno M; Abbate A; Brucato A
G Ital Cardiol (Rome); 2021 Oct; 22(10):833-843. PubMed ID: 34570117
[TBL] [Abstract][Full Text] [Related]
19. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial.
Imazio M; Bobbio M; Cecchi E; Demarie D; Demichelis B; Pomari F; Moratti M; Gaschino G; Giammaria M; Ghisio A; Belli R; Trinchero R
Circulation; 2005 Sep; 112(13):2012-6. PubMed ID: 16186437
[TBL] [Abstract][Full Text] [Related]
20. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients.
Dagan A; Langevitz P; Shoenfeld Y; Shovman O
Autoimmun Rev; 2019 Jun; 18(6):627-631. PubMed ID: 30959216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
